Clinical Trials Directory

Trials / Recruiting

RecruitingNCT02913352

Latarjet Versus Modified Eden-Hybinette for Anterior Shoulder Dislocation

Randomized Trial for the Treatment of Recurrent Anterior Dislocation of the Shoulder: Latarjet Versus Modified Eden-Hybinette

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
60 (estimated)
Sponsor
University of Sao Paulo · Academic / Other
Sex
All
Age
16 Years
Healthy volunteers
Not accepted

Summary

Randomized clinical trial, parallel 1:1, comparing Latarjet to Modified Eden-Hybinette (iliac bone crest + capsular repair) for recurrent traumatic anterior glenohumeral dislocation.

Detailed description

The Latarjet technique has proven reliable for the treatment of dislocations, with lower recurrence rates (5%) even in the presence of bone lesions. This technique allows a stable fixation of the graft, with 2 screws, and the dynamic effect of the conjoint tendon, the sling effect. However, several complications are described, such as neurological injuries, nonunion and graft resorption. Hamel et al, showed that vascularization of the coracoid graft is impaired during the course of Latarjet procedure. Together with the small thickness of the coracoid, it may justify its high rate of resorption. The Eden-Hybinette surgery does not have the potential advantages of the sling effect. However, it allows a better restoration of the area of the glenoid, without the risks related to the coracoid osteotomy. All clinical studies about the different bone grafting techniques have a low quality. Furthermore, there is no comparative study of the techniques of Latarjet and Eden-Hybinette.

Conditions

Interventions

TypeNameDescription
PROCEDURELatarjet procedureOpen anterior glenoid bone graft from coracoid process
PROCEDUREModified Eden-HybinetteOpen anterior glenoid bone graft from iliac bone crest, with capsular suture and screw fixation

Timeline

Start date
2016-09-01
Primary completion
2027-12-01
Completion
2029-12-01
First posted
2016-09-23
Last updated
2026-01-29

Locations

1 site across 1 country: Brazil

Source: ClinicalTrials.gov record NCT02913352. Inclusion in this directory is not an endorsement.